Oncology

Rochester, Minn.-based Mayo Clinic has launched a theranostics research collaboration with GE Healthcare to study personalizing radioligand therapy for patients with advanced prostate cancer.  The collaboration is called MI-BET or the Molecular Imaging Biomarker-Based End of Therapy Trial, according to…

Lung transplant can extend survival in some patients with stage 4 lung cancer, according to a study published July 8 in JAMA. Researchers and physicians from Chicago-based Northwestern Medicine analyzed data from 404 adult patients with end-stage pulmonary disease, including…

Maura Gillison, MD, PhD, a professor of medicine in thoracic/head and neck medical oncology at Houston-based University of Texas MD Anderson Cancer Center, died June 21 at the age of 61. Dr. Gillison is widely recognized as the first researcher…

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center achieved an overall one-year survival rate of 92.6% after standardizing allogeneic hematopoietic cell transplant processes and workflows, according to a study published July 5 in Transplantation and Cellular Therapy.  The most recent data…

Men were more likely than women to receive a late-stage diagnosis for 16 cancer sites between 2015 and 2022, according to a study published July 1 in Cancer Epidemiology, Biomarkers & Prevention. Researchers from the National Cancer Institute analyzed 2,401,772…

Honolulu-based University of Hawaii Cancer Center has opened the first early-phase clinical trial center in the Hawaiian Islands.  The Ho’ōla Early Phase Clinical Research Center is located within the UH Cancer Center in Honolulu’s Kaka’ako neighborhood, according to a July…

Stanley Gartler, PhD, a molecular biologist, geneticist and cancer research “pioneer,” died May 25 at age 102, according to a July 4 report from The New York Times.  Dr. Gartler was professor emeritus at the University of Washington in Seattle,…

With cancer care growing beyond hospital walls and more cancer patients surviving than ever before, health systems in the U.S. are doubling down on their oncology infrastructure commitments. “Cancer care can no longer be designed around treatment alone. We must…

Chicago-based Northwestern Medicine plans to build a $275 million cancer center in Orland Park, Ill., according to a July 1 report from the Chicago Tribune.  The project will be partially funded through a $225 million donation from the St. George…

Roanoke, Va.-based Carilion Clinic has expanded its clinical trial offerings to include radiopharmaceutical therapies.  The first trials in the pipeline will focus on cancer pain, renal cell carcinoma and glioblastoma, according to a June 26 news release from Carilion Clinic.…